FC RECEPTORS AND IA ANTIGENS.HALLORAN P; SCHIRRMACHER V.1976; IMMUNOL. COMMUNIC.; U.S.A.; DA. 1976; VOL. 5; NO 4; PP. 243-261; BIBL. 3 P. 1/2Article

AN LY-LIKE ALLOANTIGEN WITH EXTENSIVE EXPRESSION IN RENAL TISSUEDUTTON D; HALLORAN P.1979; TRANSPLANT. PROC.; USA; DA. 1979; VOL. 11; NO 2; PP. 1363-1364; BIBL. 6 REF.Article

INHIBITION OF CELL-DEPENDENT CYTOTOXICITY AS AN ASSAY FOR MOUSE ALLOANTIBODYHALLORAN P; FESTENSTEIN H.1974; NATURE; G.B.; DA. 1974; VOL. 250; NO 5461; PP. 52-54; BIBL. 13REF.Article

T Cell Mediated Rejection of Kidney Transplants: A Personal ViewpointHALLORAN, P. F.American journal of transplantation (Print). 2010, Vol 10, Num 5, pp 1126-1134, issn 1600-6135, 9 p.Article

A NEW SENSITIVE ASSAY FOR ANTIBODY AGAINST CELL SURFACE ANTIGENS BASED ON INHIBITION OF CELL DEPENDENT ANTIBODY MEDIATED CYTOTOXICITY. I. SPECIFITY AND SENSITIVITYHALLORAN P; SCHIRRMACHER V; FESTENSTEIN H et al.1974; J. EXPER. MED.; U.S.A.; DA. 1974; VOL. 140; NO 5; PP. 1348-1363; BIBL. 2 P.Article

Mechanism of action of the calcineurin inhibitorsHALLORAN, P. F.Transplantation proceedings. 2001, Vol 33, Num 7-8, pp 3067-3069, issn 0041-1345Article

INTERACTIONS OF FC RECEPTORS WITH ANTIBODIES AGAINST IA ANTIGENS AND OTHER CELL SURFACE COMPONENTSSCHIRRMACHER V; HALLORAN P; DAVID CS et al.1975; J. EXPER. MED.; U.S.A.; DA. 1975; VOL. 141; NO 5; PP. 1201-1209; BIBL. 12REF.Article

THE SPECIFICITY AND SIGNIFICANCE OF THE INHIBITION OF FC RECEPTOR BINDING BY ANTI-H-2 SERAHALLORAN P; SCHIRRMACHER V; DAVID CS et al.1975; IMMUNOGENETICS; DTSCH.; DA. 1975; VOL. 2; NO 4; PP. 349-361; BIBL. 1 P.Article

Immunosuppressive agents in clinical trials in transplantationHALLORAN, P. F.The American journal of the medical sciences. 1997, Vol 313, Num 5, pp 283-288, issn 0002-9629Article

Immunophilins may limit calcineurin inhibition by cyclosporine and tacrolimus at high drug concentrationsKUNG, L; HALLORAN, P. F.Transplantation. 2000, Vol 70, Num 2, pp 327-335, issn 0041-1337Article

Crossreactions between an I-A allospecificity and the cytoskeleton of glomerular epithelium and of vascular smooth muscleWADGYMAR, A; HALLORAN, P. F.Transplantation. 1987, Vol 43, Num 6, pp 903-908, issn 0041-1337Article

Regulation of MHC transcriptionHALLORAN, P. F; MADRENAS, J.Transplantation. 1990, Vol 50, Num 5, pp 725-738, issn 0041-1337, 14 p.Article

A NEW SENSITIVE ASSAY FOR ANTIBODY AGAINST CELL SURFACE ANTIGENS BASED ON INHIBITION OF CELL-DEPENDENT ANTIBODY-MEDIATED CYTOTOXICITY. II. MECHANISMSCHIRRMACHER V; HALLORAN P; ROSS E et al.1975; CELL. IMMUNOL.; U.S.A.; DA. 1975; VOL. 16; NO 2; PP. 362-373; BIBL. 20REF.Article

Cyclosporine blocks the induction of class I and class II MHC products in mouse kidney by graft-vs-host diseaseAUTENRIED, P; HALLORAN, P. F.The Journal of immunology (1950). 1985, Vol 135, Num 6, pp 3922-3928, issn 0022-1767Article

Sénescence rénale, sénescence cellulaire et leur rôle en néphrologie et transplantation = Renal senescence, cell senescence and their role in nephrology and transplantationHALLORAN, P. F; MELK, A.Actualités néphrologiques Jean Hamburger. 2001, pp 249-258, issn 1168-1098, 10 p.Article

A randomized prospective trial of cold storage versus pulsatile perfusion for cadaver kidney preservationHALLORAN, P; APRILE, M.Transplantation. 1987, Vol 43, Num 6, pp 827-832, issn 0041-1337Article

Differential resistance to growth of a tumor expressing incompatible minor alloantigens reflects regulatory influences rather than differences in anti-minor-CTL-P frequenciesCARAYANNIOTIS, G; HALLORAN, P. F.Cellular immunology (Print). 1985, Vol 91, Num 1, pp 100-110, issn 0008-8749Article

AUTOANTIBODY AGAINST FIBROBLASTS IN RENAL TRANSPLANT RECIPIENTS: ANALYSIS BY ⁵¹CR-RELEASE ASSAYSAPRILE M; HALLORAN P; HADDAD G et al.1981; CLIN. EXP. IMMUNOL.; ISSN 0009-9104; GBR; DA. 1981; VOL. 46; NO 3; PP. 565-574; BIBL. 25 REF.Article

Tacrolimus, MMF, steroid, and ALG immunotherapy for high immunological risk renal transplant recipientsZALTZMAN, J; MCALISTER, V; PEETS, J et al.Transplantation proceedings. 2001, Vol 33, Num 1-2, pp 1044-1045, issn 0041-1345Conference Paper

The Banff schema four years laterSOLEZ, K; RACUSEN, L; RAYNER, D et al.Transplantation proceedings. 1996, Vol 28, Num 1, pp 450-452, issn 0041-1345Conference Paper

Lake Louise consensus conference on cyclosporin monitoring in organ transplantation : report of the consensus panelOELLERICH, M; ARMSTRONG, V. W; SCHÜTZ, E et al.Therapeutic drug monitoring. 1995, Vol 17, Num 6, pp 642-654, issn 0163-4356Conference Paper

Mycophenolate mofetil : a report of the consensus panelSHAW, L. M; SOLLINGER, H. W; JAKLITSCH, A et al.Therapeutic drug monitoring. 1995, Vol 17, Num 6, pp 690-699, issn 0163-4356Conference Paper

Histopathologic Clusters Differentiate Subgroups Within the Nonspecific Diagnoses of CAN or CR: Preliminary Data from the DeKAF StudyMATAS, A. J; LEDUC, R; MANNON, R et al.American journal of transplantation (Print). 2010, Vol 10, Num 2, pp 315-323, issn 1600-6135, 9 p.Article

Cool la niña during the warmth of the Pliocene?RICKABY, R. E. M; HALLORAN, P.Science (Washington, D.C.). 2005, Vol 307, Num 5717, pp 1948-1952, issn 0036-8075, 5 p.Article

Intravenous mycophenolate mofetil : safety, tolerability, and pharmacokineticsPESCOVITZ, M; CONTI, D; KITTUR, D et al.Clinical transplantation. 2000, Vol 14, Num 3, pp 179-188, issn 0902-0063Article